Trails Edge Capital Partners »

Ocuphire Pharma shares owned by Trails Edge Capital Partners

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Trails Edge Capital Partners from 13F filings

Historical chart of Trails Edge Capital Partners investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Trails Edge Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Trails Edge Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.3M 500k 4.55

More positions owned by Trails Edge Capital Partners

Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Definium Therapeutics Com Shs (DFTX)
Lb Pharmaceuticals Com Shs (LBRX)
Mirum Pharmaceuticals (MIRM)
Nurix Therapeutics (NRIX)
Revolution Medicines (RVMD)
Arcus Biosciences Incorporated (RCUS)
Immunocore Hldgs Ads (IMCR)
Cytokinetics Com New (CYTK)
Syndax Pharmaceuticals (SNDX)
Neurogene (NGNE)
Inventiva Sa Ads (IVA)
Inhibikase Therapeutics Com New (IKT)
4d Molecular Therapeutics In (FDMT)

View all positions for Trails Edge Capital Partners

Top funds holding Ocuphire Pharma

BIOS Capital Management
Balyasny Asset Management
Millennium Management
Vanguard Capital Management
Vanguard Group
ADAR1 Capital Management
Perceptive Advisors
Nantahala Capital Management
Woodline Partners
Boothbay Fund Management
Opaleye Management
Adage Capital Partners GP
Bleichroeder
Mink Brook Asset Management
Geode Capital Management

View all funds holding Ocuphire Pharma